The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

United States Food and Drug Administration

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of United States Food and Drug Administration

 

Psychiatry related information on United States Food and Drug Administration

 

High impact information on United States Food and Drug Administration

 

Chemical compound and disease context of United States Food and Drug Administration

 

Biological context of United States Food and Drug Administration

 

Anatomical context of United States Food and Drug Administration

 

Associations of United States Food and Drug Administration with chemical compounds

 

Gene context of United States Food and Drug Administration

 

Analytical, diagnostic and therapeutic context of United States Food and Drug Administration

References

  1. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. Malinow, M.R., Duell, P.B., Hess, D.L., Anderson, P.H., Kruger, W.D., Phillipson, B.E., Gluckman, R.A., Block, P.C., Upson, B.M. N. Engl. J. Med. (1998) [Pubmed]
  2. Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. Pierce, L.R., Wysowski, D.K., Gross, T.P. JAMA (1990) [Pubmed]
  3. Effect of race on access to recombinant human erythropoietin in long-term hemodialysis patients. Petronis, K.R., Carroll, C.E., Held, P.J., Port, F.K. JAMA (1994) [Pubmed]
  4. Change in public perspective on cholesterol and heart disease. Results from two national surveys. Schucker, B., Bailey, K., Heimbach, J.T., Mattson, M.E., Wittes, J.T., Haines, C.M., Gordon, D.J., Cutler, J.A., Keating, V.S., Goor, R.S. JAMA (1987) [Pubmed]
  5. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. Albers, G.W., Bates, V.E., Clark, W.M., Bell, R., Verro, P., Hamilton, S.A. JAMA (2000) [Pubmed]
  6. Prevention of hormone-related cancers: breast cancer. Dunn, B.K., Wickerham, D.L., Ford, L.G. J. Clin. Oncol. (2005) [Pubmed]
  7. Bupropion sustained release and smoking cessation. Goldstein, M.G. The Journal of clinical psychiatry. (1998) [Pubmed]
  8. A systematic review of modafinil: potential clinical uses and mechanisms of action. Ballon, J.S., Feifel, D. The Journal of clinical psychiatry. (2006) [Pubmed]
  9. Buspirone: future directions. Apter, J.T., Allen, L.A. Journal of clinical psychopharmacology. (1999) [Pubmed]
  10. Current concepts in the treatment of panic disorder. Sheehan, D.V. The Journal of clinical psychiatry. (1999) [Pubmed]
  11. Pharmacotherapy for nicotine dependence. Henningfield, J.E., Fant, R.V., Buchhalter, A.R., Stitzer, M.L. CA: a cancer journal for clinicians. (2005) [Pubmed]
  12. The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants. Muennig, P., Pallin, D., Sell, R.L., Chan, M.S. N. Engl. J. Med. (1999) [Pubmed]
  13. Valvular heart disease associated with fenfluramine-phentermine. Connolly, H.M., Crary, J.L., McGoon, M.D., Hensrud, D.D., Edwards, B.S., Edwards, W.D., Schaff, H.V. N. Engl. J. Med. (1997) [Pubmed]
  14. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Wang, X., Lee, S.R., Arai, K., Lee, S.R., Tsuji, K., Rebeck, G.W., Lo, E.H. Nat. Med. (2003) [Pubmed]
  15. Histamine poisoning associated with eating tuna burgers. Becker, K., Southwick, K., Reardon, J., Berg, R., MacCormack, J.N. JAMA (2001) [Pubmed]
  16. Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. Freedman, A.N., Graubard, B.I., Rao, S.R., McCaskill-Stevens, W., Ballard-Barbash, R., Gail, M.H. J. Natl. Cancer Inst. (2003) [Pubmed]
  17. Photodynamic therapy in oncology: mechanisms and clinical use. Pass, H.I. J. Natl. Cancer Inst. (1993) [Pubmed]
  18. Sulindac-associated hepatic injury: analysis of 91 cases reported to the Food and Drug Administration. Tarazi, E.M., Harter, J.G., Zimmerman, H.J., Ishak, K.G., Eaton, R.A. Gastroenterology (1993) [Pubmed]
  19. Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases. Bennett, C.L., Weinberg, P.D., Rozenberg-Ben-Dror, K., Yarnold, P.R., Kwaan, H.C., Green, D. Ann. Intern. Med. (1998) [Pubmed]
  20. Bleomycin. Bennett, J.M., Reich, S.D. Ann. Intern. Med. (1979) [Pubmed]
  21. The challenge of regulating health claims and food fortification. Yetley, E.A., Rader, J.I. J. Nutr. (1996) [Pubmed]
  22. Removal of INTACS for myopia. Clinch, T.E., Lemp, M.A., Foulks, G.N., Schanzlin, D.J. Ophthalmology (2002) [Pubmed]
  23. Effect of pentoxifylline on Wrb antigen. Tweedy, C.J., Kalish, R.I., Cummings, E.A., Snyder, E.L., Tweedy, C.R. Transfusion (1987) [Pubmed]
  24. Remission in rheumatoid arthritis: wishful thinking or clinical reality? Sesin, C.A., Bingham, C.O. Semin. Arthritis Rheum. (2005) [Pubmed]
  25. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs. Borgheini, G. Clinical therapeutics. (2003) [Pubmed]
  26. Rituximab: an insider's historical perspective. Grillo-López, A.J. Semin. Oncol. (2000) [Pubmed]
  27. Microsporidial AIDS cholangiopathy due to Encephalitozoon intestinalis: case report and review. Sheikh, R.A., Prindiville, T.P., Yenamandra, S., Munn, R.J., Ruebner, B.H. Am. J. Gastroenterol. (2000) [Pubmed]
  28. Introduction of trimethoprim: a mixed blessing. Gleckman, R.A. Urology (1981) [Pubmed]
  29. Intrathecal baclofen for severe spasticity secondary to spinal cord injury. Lewis, K.S., Mueller, W.M. The Annals of pharmacotherapy. (1993) [Pubmed]
  30. Vagus nerve stimulation in pediatric epilepsy: a review. Valencia, I., Holder, D.L., Helmers, S.L., Madsen, J.R., Riviello, J.J. Pediatric neurology. (2001) [Pubmed]
  31. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. Honein, M.A., Paulozzi, L.J., Mathews, T.J., Erickson, J.D., Wong, L.Y. JAMA (2001) [Pubmed]
  32. From the Food and Drug Administration. Update on zidovudine. Nightingale, S.L. JAMA (1988) [Pubmed]
  33. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism. Dong, B.J., Hauck, W.W., Gambertoglio, J.G., Gee, L., White, J.R., Bubp, J.L., Greenspan, F.S. JAMA (1997) [Pubmed]
  34. Contraindicated use of cisapride: impact of food and drug administration regulatory action. Smalley, W., Shatin, D., Wysowski, D.K., Gurwitz, J., Andrade, S.E., Goodman, M., Chan, K.A., Platt, R., Schech, S.D., Ray, W.A. JAMA (2000) [Pubmed]
  35. Nitrates, package inserts, and the Food and Drug Administration. A clinical paradox. Abrams, J. JAMA (1981) [Pubmed]
  36. Cytokines in rheumatoid arthritis: trials and tribulations. Carteron, N.L. Molecular medicine today. (2000) [Pubmed]
  37. Etanercept: therapeutic use in patients with rheumatoid arthritis. Garrison, L., McDonnell, N.D. Ann. Rheum. Dis. (1999) [Pubmed]
  38. Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumors. Janik, J.E., Sznol, M., Urba, W.J., Figlin, R., Bukowski, R.M., Fyfe, G., Pierce, W.C., Belldegrun, A., Sharfman, W.H., Smith, J.W. Cancer (1993) [Pubmed]
  39. Tumor necrosis factor inhibitors: new options for treating rheumatoid arthritis. Moreland, L.W. Isr. Med. Assoc. J. (2001) [Pubmed]
  40. Advances in molecular diagnostics and therapeutics in head and neck cancer. Chai, R.L., Grandis, J.R. Current treatment options in oncology. (2006) [Pubmed]
  41. New approaches to anti-inflammatory therapy for asthma. Wenzel, S.E. Am. J. Med. (1998) [Pubmed]
  42. United States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tablets. Cohen, M.H., Williams, G.A., Sridhara, R., Chen, G., McGuinn, W.D., Morse, D., Abraham, S., Rahman, A., Liang, C., Lostritto, R., Baird, A., Pazdur, R. Clin. Cancer Res. (2004) [Pubmed]
  43. Thiol proteases: inhibitors and potential therapeutic targets. Leung-Toung, R., Zhao, Y., Li, W., Tam, T.F., Karimian, K., Spino, M. Current medicinal chemistry. (2006) [Pubmed]
  44. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer. Liao, Z., Komaki, R., Milas, L., Yuan, C., Kies, M., Chang, J.Y., Jeter, M., Guerrero, T., Blumenschien, G., Smith, C.M., Fossella, F., Brown, B., Cox, J.D. Clin. Cancer Res. (2005) [Pubmed]
  45. Diagnostic performance of Food and Drug Administration-cleared serologic assays for natural rubber latex-specific IgE antibody. The Multi-Center Latex Skin Testing Study Task Force. Hamilton, R.G., Biagini, R.E., Krieg, E.F. J. Allergy Clin. Immunol. (1999) [Pubmed]
 
WikiGenes - Universities